Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Anderson JJ, Lau EM, Lavender M, Benza R, Celermajer DS, Collins N, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keating D, Kermeen F, Kotlyar E, McWilliams T, Rhodes B, Steele P, Thakkar V, Williams T, Whitford H, Whyte K, Weintraub R, Wrobel JP, Keogh A, Strange G. Anderson JJ, et al. Chest. 2020 Jan;157(1):162-172. doi: 10.1016/j.chest.2019.08.2203. Epub 2019 Sep 26. Chest. 2020. PMID: 31563497
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry.
Khou V, Anderson JJ, Strange G, Corrigan C, Collins N, Celermajer DS, Dwyer N, Feenstra J, Horrigan M, Keating D, Kotlyar E, Lavender M, McWilliams TJ, Steele P, Weintraub R, Whitford H, Whyte K, Williams TJ, Wrobel JP, Keogh A, Lau EM. Khou V, et al. Among authors: anderson jj. Respirology. 2020 Aug;25(8):863-871. doi: 10.1111/resp.13768. Epub 2020 Jan 30. Respirology. 2020. PMID: 31997504
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.
Anderson J, Lavender M, Lau E, Celermajer D, Collins N, Dwyer N, Feenstra J, Horrigan M, Keating D, Keogh A, Kotlyar E, Ng B, Proudman S, Steele P, Thakkar V, Weintraub R, Whitford H, Williams T, Wrobel J, Strange G. Anderson J, et al. Heart Lung Circ. 2020 Oct;29(10):1459-1468. doi: 10.1016/j.hlc.2020.01.017. Epub 2020 Mar 6. Heart Lung Circ. 2020. PMID: 32280014
Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
Ratwatte S, Anderson J, Strange G, Corrigan C, Collins N, Celermajer DS, Dwyer N, Feenstra J, Keating D, Kotlyar E, Lavender M, Whitford H, Whyte K, Williams T, Wrobel JP, Keogh A, Lau EM; PHSANZ Registry. Ratwatte S, et al. Eur Respir J. 2020 Jul 9;56(1):1901654. doi: 10.1183/13993003.01654-2019. Print 2020 Jul. Eur Respir J. 2020. PMID: 32341105 Free article.
Risk stratification in pulmonary arterial hypertension using Bayesian analysis.
Kanwar MK, Gomberg-Maitland M, Hoeper M, Pausch C, Pittrow D, Strange G, Anderson JJ, Zhao C, Scott JV, Druzdzel MJ, Kraisangka J, Lohmueller L, Antaki J, Benza RL. Kanwar MK, et al. Among authors: anderson jj. Eur Respir J. 2020 Aug 27;56(2):2000008. doi: 10.1183/13993003.00008-2020. Print 2020 Aug. Eur Respir J. 2020. PMID: 32366491 Free PMC article.
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry.
Kearney K, Gold J, Corrigan C, Dhital K, Boshell D, Haydock D, McGiffin D, Wilson M, Collins N, Cordina R, Dwyer N, Feenstra J, Lavender M, Wrobel J, Whitford H, Williams T, Keating D, Whyte K, McWilliams T, Keogh A, Strange G, Kotlyar E, Anderson J, Lau EM. Kearney K, et al. Respirology. 2021 Dec;26(12):1171-1180. doi: 10.1111/resp.14162. Epub 2021 Oct 5. Respirology. 2021. PMID: 34608706
Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
Chandrasekara S, Lau EM, Anderson J, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keogh A, Kotlyar E, Lavender M, McWilliams T, Rhodes B, Steele P, Strange G, Thakkar V, Weintraub R, Whitford H, Whyte K, Williams T, Wrobel J, Keating DT; PHSANZ Registry. Chandrasekara S, et al. Heart Lung Circ. 2023 Feb;32(2):156-165. doi: 10.1016/j.hlc.2022.09.005. Epub 2022 Dec 8. Heart Lung Circ. 2023. PMID: 36503731
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
Kearney K, Brown K, Celermajer DS, Collins N, Cordina R, Corrigan C, Dwyer N, Feenstra J, Keating D, Keogh A, Kotlyar E, Lavender M, McWilliams T, Williams T, Whitford H, Weintraub R, Wrobel J, Ellender C, Anderson J, Lau EM; PHSANZ Registry. Kearney K, et al. Chest. 2024 Apr;165(4):967-977. doi: 10.1016/j.chest.2023.10.037. Epub 2023 Nov 10. Chest. 2024. PMID: 37951349
389 results